Carl Zeiss Meditec (AFX) PT Set at €71.00 by Deutsche Bank

Carl Zeiss Meditec (ETR:AFX) has been given a €71.00 ($82.56) price target by analysts at Deutsche Bank in a report released on Tuesday. The firm currently has a “neutral” rating on the stock. Deutsche Bank’s target price points to a potential downside of 12.29% from the company’s previous close.

AFX has been the subject of several other research reports. Berenberg Bank set a €63.00 ($73.26) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Friday, December 7th. Nord/LB set a €86.00 ($100.00) price objective on Carl Zeiss Meditec and gave the company a “buy” rating in a report on Monday, January 21st. Independent Research set a €73.00 ($84.88) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Wednesday, December 12th. Hauck & Aufhaeuser set a €78.50 ($91.28) price objective on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Thursday, January 24th. Finally, HSBC set a €75.00 ($87.21) price objective on Carl Zeiss Meditec and gave the company a “buy” rating in a report on Tuesday, December 4th. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have issued a buy rating to the stock. Carl Zeiss Meditec currently has an average rating of “Hold” and a consensus target price of €72.31 ($84.08).

AFX stock opened at €80.95 ($94.13) on Tuesday. Carl Zeiss Meditec has a 1 year low of €37.53 ($43.64) and a 1 year high of €55.25 ($64.24).

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Story: Trading Strategy Methods and Types

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply